Single-agent chemotherapy Clinical Trials
2 recruitingDrug
Phase 21Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 3
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Advanced Melanoma
Replimune Inc.400 enrolled73 locationsNCT06264180
Recruiting
Phase 2
Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab
Non-small-cell Lung Cancer Patients
Fondazione Ricerca Traslazionale176 enrolled1 locationNCT05568212